(Q28202893)

https://api.crossref.org/works/10.1002%2FJEMT.10173

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Cloning and characterization of the promoter for the rat insulin-like growth factor-binding protein-3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

p53 in signaling checkpoint arrest or apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Circulating binding proteins for the insulinlike growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor binding proteins as glucoregulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Transformation by v-sis occurs by an internal autoactivation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Autocrine and paracrine growth inhibitors of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Induction of the growth inhibitor IGF-binding protein 3 by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Glycosylation of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) is not Required for Potentiation IGF-I Action: Evidence for Processing of Cell-Bound IGFBP-3*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

The NH2-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

The RXR heterodimers and orphan receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor beta in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

IGF-independent regulation of breast cancer growth by IGF binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor physiology and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Bcl-2 and the regulation of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Regulation of insulin-like growth factor binding protein secretion by a murine mammary epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

The state of differentiation of embryonic chicken lens cells determines insulin-like growth factor I internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Transforming growth factor beta and its receptors: their role in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Generation and characterization of an IGFBP-7 antibody: identification of 31kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Retinoid receptors in human lung cancer and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10173